Insider Trading24 Sept 2026, 10:02 pm
Goldline Pharmaceutical Ltd Closes Trading Window
AI Summary
Goldline Pharmaceutical Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the half-year ended September 30, 2026. The specific date for the board meeting to consider these results will be communicated separately. The company has also made this intimation available on its website.
Key Highlights
- Trading window closed for designated persons from Oct 1, 2026.
- Closure is for consideration of H1 FY27 financial results.
- Window reopens 48 hours after results declaration.
- Board meeting date for results to be announced later.
Price Impact
More from GLPL